Trial: 201810185

Effect of rhIL-7-hyFc on increasing lymphocyte counts in patients with newly diagnosed non-severe lymphopenic gliomas following radiation and temozolomide

Phase

I/II

Principal Investigator

Chheda, Milan

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov